#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16992	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	805.0	0	.	n	.	0	C1200T	SNP	1200	1200	C	1478	1478	T	913	T,C	461,386	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16992	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	805.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1462	1462	C	989	C	926	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	0	.	n	.	0	T695C	SNP	695	695	T	995	995	C	927	C,T,A	868,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1938	1938	G	974	G,A	676,223	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2271	2271	C	1004	C	948	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2345	2345	A	1033	A	973	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2897	2897	C	981	C,T	918,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31272	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3604	865.2	0	HET	.	.	.	C2525T,A	.	2525	2525	C	2825	2825	C	1029	C,T,A	709,262,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2344	folP	855	855	100.0	folP.l15.c4.ctg.1	1490	156.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1052	1054	AGC	239;238;236	A;G;C	230;229;226	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3376	178.8	1	SNP	p	S91F	1	.	.	271	273	TTC	534	536	TTC	182;184;185	T;T;C	165;166;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3376	178.8	1	SNP	p	G95N	0	.	.	283	285	GGC	546	548	GGC	185;186;187	G;G;C	168;167;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3376	178.8	1	SNP	p	D95G	1	.	.	283	285	GGC	546	548	GGC	185;186;187	G;G;C	168;167;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1914	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1288	147.5	1	SNP	p	G45D	0	.	.	133	135	GGC	441	443	GGC	230;233;232	G;G;C	215;218;218	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	948	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	955	98.9	0	.	n	.	0	A197.	DEL	197	197	A	552	552	A	219	A	206	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5842	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2912	199.9	1	SNP	p	D86N	0	.	.	256	258	GAC	521	523	GAC	207;205;206	G;A;C	194;187;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5842	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2912	199.9	1	SNP	p	R87I	0	.	.	259	261	CGT	524	526	CGT	206;204;206	C;G;T,C	194;191;192,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5842	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2912	199.9	1	SNP	p	S87R	1	.	.	259	261	CGT	524	526	CGT	206;204;206	C;G;T,C	194;191;192,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5842	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2912	199.9	1	SNP	p	R87W	0	.	.	259	261	CGT	524	526	CGT	206;204;206	C;G;T,C	194;191;192,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5842	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2912	199.9	1	SNP	p	S88P	0	.	.	262	264	TCC	527	529	TCC	206;207;206	T;C;C	195;195;196	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4918	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2635	185.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	246;243;244	G;G;C	228;226;222	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	P551S	1	P551S	NONSYN	1651	1653	CCG	1996	1998	TCG	257;256;254	T,G;C;G	189,5;213;210	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1276	1278	GCC	267;268;269	G;C;C,A	253;252;252,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1279	1281	ATG	269;269;268	A;T;G,C	255;252;253,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1291	1293	ACC	260;258;262	A,G;C;C,G	246,1;243;246,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1291	1293	ACC	260;258;262	A,G;C;C,G	246,1;243;246,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1792	1794	ACC	251;252;255	A;C;C	231;235;242	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1846	1848	GCG	242;242;241	G;C;G	228;225;227	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1846	1848	GCG	242;242;241	G;C;G	228;225;227	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1969	1971	GGT	260;257;257	G;G;T	233;235;231	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	4926	penA	1746	1746	99.94	penA.l15.c30.ctg.1	2560	191.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1978	1980	AGC	258;255;254	A;G;C	233;228;229	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6394	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3187	200.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1708	1710	CCG	230;226;226	C;C;G	202;205;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2442	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1834	132.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	173	C	162	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	0	.	p	.	0	E41K	NONSYN	121	123	GAA	446	448	AAA	283;284;284	A;A;A	272;271;270	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	0	.	p	.	0	N214del	DEL	640	640	A	964	964	T	279	T	262	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	0	.	p	.	0	A320V	NONSYN	958	960	GCC	1280	1282	GTC	231;229;225	G;T;C	214;214;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	1	SNP	p	G120K	1	.	.	358	360	AAG	683	685	AAG	276;277;279	A;A;G	264;264;258	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	1	SNP	p	N121D	0	.	.	361	363	AAC	686	688	AAC	279;279;276	A;A;C	264;263;262	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3202	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1556	203.2	1	SNP	p	A121N	1	.	.	361	363	AAC	686	688	AAC	279;279;276	A;A;C	264;263;262	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12468	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5021	247.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1320	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	877	147.6	1	SNP	p	V57M	1	.	.	169	171	ATG	497	499	ATG	273;275;274	A;T;G	256;255;254	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
